Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
February 12, 2013
|
February 12, 2013
|
February 12, 2013
|
February 8, 2013
|
|
February 7, 2013
|
January 21, 2013
|
December 20, 2012
|
September 18, 2012
|